HK1203981A1 - Coagulation factor viii with reduced immunogenicity viii - Google Patents
Coagulation factor viii with reduced immunogenicity viiiInfo
- Publication number
- HK1203981A1 HK1203981A1 HK15104600.7A HK15104600A HK1203981A1 HK 1203981 A1 HK1203981 A1 HK 1203981A1 HK 15104600 A HK15104600 A HK 15104600A HK 1203981 A1 HK1203981 A1 HK 1203981A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- viii
- coagulation factor
- reduced immunogenicity
- factor viii
- immunogenicity
- Prior art date
Links
- 102000001690 Factor VIII Human genes 0.000 title 1
- 108010054218 Factor VIII Proteins 0.000 title 1
- 229940105778 coagulation factor viii Drugs 0.000 title 1
- 230000005847 immunogenicity Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/20—Ingredients acting on or related to the structure
- A23V2200/218—Coagulant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0413—Blood
- A61M2202/0445—Proteins
- A61M2202/0447—Glycoproteins
- A61M2202/0452—Factor VIII
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12168800.6A EP2666782A1 (en) | 2012-05-22 | 2012-05-22 | Coagulation factor VIII with reduced immunogenicity. |
| PCT/EP2013/060397 WO2013174805A1 (en) | 2012-05-22 | 2013-05-21 | Coagulation factor viii with reduced immunogenicity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1203981A1 true HK1203981A1 (en) | 2015-11-06 |
Family
ID=48485166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15104600.7A HK1203981A1 (en) | 2012-05-22 | 2015-05-14 | Coagulation factor viii with reduced immunogenicity viii |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10087233B2 (ru) |
| EP (2) | EP2666782A1 (ru) |
| JP (1) | JP6363996B2 (ru) |
| AU (1) | AU2013265400B2 (ru) |
| BR (1) | BR112014028575B1 (ru) |
| CA (1) | CA2872938C (ru) |
| DK (1) | DK2852609T3 (ru) |
| ES (1) | ES2751361T3 (ru) |
| HK (1) | HK1203981A1 (ru) |
| IN (1) | IN2014DN09216A (ru) |
| RU (1) | RU2631801C2 (ru) |
| WO (1) | WO2013174805A1 (ru) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3388447A1 (en) * | 2017-04-14 | 2018-10-17 | Imnate Sarl | Methods to produce peptides, polypeptides or cells for modulating immunity |
| EP3936867A1 (en) | 2020-07-06 | 2022-01-12 | Imnate Sarl | Cd1 peptide-epitope for use in the treatment of a disease caused by an intracellular pathogen |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7084251B1 (en) * | 1987-02-12 | 2006-08-01 | Genentech, Inc. | Methods and Deoxyribonucleic acid for the preparation of tissue factor protein |
| US5859204A (en) * | 1992-04-07 | 1999-01-12 | Emory University | Modified factor VIII |
| WO1995006737A1 (en) * | 1993-09-03 | 1995-03-09 | Kenneth Francis Prendergast | Glycophorin binding protein (gbp130) fusion compositions |
| US6458563B1 (en) * | 1996-06-26 | 2002-10-01 | Emory University | Modified factor VIII |
| MXPA04010061A (es) * | 2002-04-18 | 2004-12-13 | Merck Patent Gmbh | Factor viii modificado. |
| PT2371856T (pt) | 2004-11-12 | 2022-08-12 | Bayer Healthcare Llc | Modificação de fviii direcionada a sítio |
| WO2006103298A2 (en) * | 2005-04-01 | 2006-10-05 | Novo Nordisk Health Care Ag | Blood coagulation fviii analogues |
| US20090110861A1 (en) | 2007-10-29 | 2009-04-30 | 3M Innovative Properties Company | Pressure sensitive adhesive article |
| CA2703948A1 (en) * | 2007-11-01 | 2009-05-07 | University Of Rochester | Recombinant factor viii having increased stability |
| EP3075391A1 (en) | 2008-02-14 | 2016-10-05 | Life Sciences Research Partners VZW | Strategies to prevent and/or treat immune responses to soluble allofactors |
| EP2149603A1 (en) * | 2008-07-28 | 2010-02-03 | DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH | Factor IX variants with clotting activity in absence of their cofactor and their use for treating bleeding disorders |
| US8691211B2 (en) * | 2009-03-10 | 2014-04-08 | Puget Sound Blood Center | Suppression of immune response to factor VIII in hemophilia A patients |
| CA2780761A1 (en) * | 2009-11-13 | 2011-05-19 | Puget Sound Blood Center | Factor viii t cell epitope variants having reduced immunogenicity |
| ES2663862T3 (es) * | 2010-11-25 | 2018-04-17 | Imnate Sarl | Modulación de inmunogenicidad de antígeno mediante la eliminación de epítopos reconocidos por linfocitos NKT |
-
2012
- 2012-05-22 EP EP12168800.6A patent/EP2666782A1/en not_active Withdrawn
-
2013
- 2013-05-21 RU RU2014151719A patent/RU2631801C2/ru active
- 2013-05-21 WO PCT/EP2013/060397 patent/WO2013174805A1/en active Application Filing
- 2013-05-21 JP JP2015513137A patent/JP6363996B2/ja not_active Expired - Fee Related
- 2013-05-21 DK DK13724802T patent/DK2852609T3/da active
- 2013-05-21 US US14/402,922 patent/US10087233B2/en active Active
- 2013-05-21 BR BR112014028575-6A patent/BR112014028575B1/pt not_active IP Right Cessation
- 2013-05-21 EP EP13724802.7A patent/EP2852609B1/en active Active
- 2013-05-21 CA CA2872938A patent/CA2872938C/en active Active
- 2013-05-21 ES ES13724802T patent/ES2751361T3/es active Active
- 2013-05-21 AU AU2013265400A patent/AU2013265400B2/en not_active Ceased
-
2014
- 2014-11-03 IN IN9216DEN2014 patent/IN2014DN09216A/en unknown
-
2015
- 2015-05-14 HK HK15104600.7A patent/HK1203981A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2872938C (en) | 2020-06-16 |
| EP2666782A1 (en) | 2013-11-27 |
| AU2013265400A1 (en) | 2014-11-13 |
| AU2013265400B2 (en) | 2017-07-27 |
| BR112014028575B1 (pt) | 2022-08-30 |
| US10087233B2 (en) | 2018-10-02 |
| DK2852609T3 (da) | 2019-11-25 |
| JP2015518844A (ja) | 2015-07-06 |
| EP2852609A1 (en) | 2015-04-01 |
| RU2631801C2 (ru) | 2017-09-26 |
| CA2872938A1 (en) | 2013-11-28 |
| JP6363996B2 (ja) | 2018-07-25 |
| IN2014DN09216A (ru) | 2015-07-10 |
| WO2013174805A1 (en) | 2013-11-28 |
| ES2751361T3 (es) | 2020-03-31 |
| RU2014151719A (ru) | 2016-07-10 |
| US20150087593A1 (en) | 2015-03-26 |
| BR112014028575A2 (pt) | 2017-08-01 |
| EP2852609B1 (en) | 2019-10-09 |